Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals

Journal of Clinical Microbiology

Volumn 38, Issue 6, 2000, Pages 2423-2426

  Jabra Rizk, M A ^a   Falkler Jr , W A ^a   Merz, W G ^b   Baqui, A A M A ^a   Kelley, J I ^a   Meiller, T F ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; CLINICAL LABORATORY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUSOBACTERIUM NUCLEATUM; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0034130746     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/.38.6.2423-2426.2000     Document Type: Article

References (31)

1. Boerlin, P., F. Loeriin-Petzold, C. Durussel, M. Addo, J.-L. Pagani, J.-P. Chave, and J. Bille. 1995. Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J. Clin. Microbiol. 33:1129-1135.
2. Coleman, D., M. Rinaldi, K. Haynes, J. Rex, R. Summerbell, E. Anaissie, A. Li, and D. Sullivan. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36(Suppl. 1):156-165.
3. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanky. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
4. Gilfillan, G. D., D. J. Sullivan, K. Haynes, T. Parkinson, D. C. Coleman, and N. A. R. Gow. 1998. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144:829-838.
5. Hazen, K. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
6. Jabra-Rizk, M. A., A. A. M. A. Baqui, J. I. Kelley, W. A. Falkler, Jr., W. G. Merz, and T. F. Meiller. 1999. Identification of Candida dubliniensis in a prospective study of patients in the United States. J. Clin. Microbiol. 37: 321-326.
7. Jabra-Rizk, M. A., W. A. Falkler, Jr., W. G. Merz, J. I. Kelley, A. A. M. A. Baqui, and T. F. Meiller. 1999. Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation. Rev. Iberoam. Micol. 16:8-14.
8. Jabra-Rizk, M. A., W. A. Falkler, Jr., W. G. Merz, J. I. Kelley, A. A. M. A. Baqui, and T. F. Meiller. 1999. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J. Clin. Microbiol. 37:1464-1468.
9. King, D., J. Rhine-Chalberg, M. A. Pfaller, S. A. Moser, and W. G. Merz. 1995. Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J. Clin. Microbiol. 33:1467-1470.
10. McCullough, M., B. Ross, and P. Reade. 1995. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 33:696-700.
11. Meiller, T. F., M. A. Jabra-Rizk, A. A. M. A. Baqui, J. I. Kelley, V. I. Meeks, W. G. Merz, and W. A. Falkler, Jr. 1999. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88:573-580.
12. Meis, J. F. G. M., M. Ruhnke, B. E. De Pauw, F. C. Odds, W. Siegert, and P. E. Verweij. 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153.
13. Moore, W. E. C., L. V. Holdeman, E. P. Cato, et al. 1985. Comparative bacteriology of juvenile periodontitis. Infect. Immun. 48:507-519.
14. Moore, W. E. C., L. V. Holdeman, E. P. Cato, R. M. Smibert, J. A. Burmeister, and R. R. Ranney. 1982. Bacteriology of moderate (chronic) periodontitis in mature human adults. Infect. Immun. 41:510-515.
15. Moran, G. P., D. Sanglard, S. M. Donnelly, D. Shanley, D. J. Sullivan, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830.
16. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
17. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Odds, F. C., L. Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869-2873.
19. Pincus, D. H., D. C. Coleman, W. R. Pruitt, A. A. Padhye, I. F. Salkin, M. Geimer, A. Bassel, D. J. Sullivan, M. Clarke, and V. Hearn. 1999. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J. Clin. Microbiol. 37:3533-3539.
20. Pinjon, E., D. Sullivan, I. Salkin, D. Shanley, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095.
21. Polacheck, I., J. Strahilevitz, D. Sullivan, S. Donnelly, I. F. Salkin, and D. C. Coleman. 2000. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J. Clin. Microbiol. 38:170-174.
22. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro/in vivo correlation data for fluconazole, intraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
23. Salkin, I. F., W. R. Pruitt, A. A. Padhye, D. Sullivan, D. Coleman, and D. H. Pincus. 1998. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J. Clin. Microbiol. 36:1467.
24. Sullivan, D., D. Bennett, M. Henman, P. Harwood, S. Flint, F. Mulcahy, D. Shanley, and D. Coleman. 1993. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J. Clin. Microbiol. 31:2124-2133.
25. Sullivan, D., and D. Coleman. 1997. Candida dubliniensis: an emerging opportunistic pathogen. Curr. Top. Med. Mycol. 8:15-25.
26. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
27. Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
28. Sullivan, D., T. Westerneng, K. A. Haynes, D. Bennett, and D. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 141:1507-1521.
29. Sullivan, D. J., G. Moran, S. Donnelly, S. Gee, E. Pinjon, B. McCartan, D. B. Shanley, and D. C. Coleman. 1999. Candida dubliniensis: an update. Rev. Iberoam. Micol. 16:72-76.
30. Velegraki, A., and M. Logotheti. 1998. Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp.nov.) reduces 2,3,5-triphenyltetrazolium chloride. FEMS Immunol. Med. Microbiol. 20:239-241.
31. Velegraki, A, O. Nicolalau, M. Theodoridou, G. Mostrou, and N. J. Legakis. 1999. Pediatric AIDS-related linear gingival erythema: a form of erythematous candidiasis. J. Oral Pathol. Med. 28:178-182.